Annovis Bio
ANVS
ANVS
32 hedge funds and large institutions have $14.4M invested in Annovis Bio in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $22.6M → $14.4M (-$8.15M)
51% less call options, than puts
Call options by funds: $12.4M | Put options by funds: $25.4M
Holders
32
Holding in Top 10
–
Calls
$12.4M
Puts
$25.4M
Top Buyers
| 1 | +$676K | |
| 2 | +$245K | |
| 3 | +$179K | |
| 4 |
LIG
Lokken Investment Group
Lewes,
Delaware
|
+$146K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$133K |
Top Sellers
| 1 | -$609K | |
| 2 | -$421K | |
| 3 | -$230K | |
| 4 |
Jane Street
New York
|
-$224K |
| 5 |
Citigroup
New York
|
-$209K |